Disruption of glucose tolerance caused by glucocorticoid excess in rats is partially prevented, But not attenuated, By arjunolic acid

Indian Journal of Experimental Biology

Volumn 52, Issue 10, 2014, Pages 972-982

  Gonçalves Neto, Luiz M ^a   Ferreira, Francielle B D ^a   Souza, Luiz ^a   dos Santos, Cristiane ^a   Boschero, Antonio C ^b   Facundo, Valdir A ^c   Santos, Adair R S ^a   Nunes, Everson A ^a   Rafacho, Alex ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Universidado Federal de Rondonia Unir   (Brazil)

Author keywords

Arjunolic acid; Glucocorticoid; Glucose tolerance; Insulin sensitivity; Metabolism

Indexed keywords

COMBRETACEAE; RATTUS; RATTUS NORVEGICUS;

ARJUNOLIC ACID; GLUCOCORTICOID; GLUCOSE BLOOD LEVEL; INSULIN; LIPID; TRITERPENE;

ANIMAL; BLOOD; BODY WEIGHT; CHEMISTRY; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; LIVER; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; GLUCOCORTICOIDS; INSULIN; LIPIDS; LIVER; MALE; ORGAN SIZE; RATS; RATS, WISTAR; TRITERPENES;

EID: 84921886633     PISSN: 00195189     EISSN: 09751009     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ortsäter H, Sjöholm A & Rafacho A, Regulation of glucocorticoid receptor signaling and the diabetogenic effects of glucocorticoid excess, in State of the art of therapeutic endocrinology (InTech, Rijeka) 2012, 1.
2. Rhen T & Cidlowski JA, Antiinflammatory action of glucocorticoids: New mechanisms for old drugs, N Engl J Med, 353 (2005) 1711.
3. Schäcke H, Döcke WD & Asadullah K, Mechanims involved in the side effects of glucocorticoids, Pharmacol Ther, 96 (2002) 23.
4. Wajngot A, Giacca A, Grill V, Vranic M & Efendic S, The diabetogenic effects of glucocorticoids are more pronounced in low- than in high-insulin responders, Proc Natl Acad Sci USA, 89 (1992) 6035.
5. Schneiter P & Tappy L, Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans, Am J Physiol, 275 (1998) E806.
6. Nicod N, Giusti V, Besse C & Tappy L, Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers, Obes Res, 11 (2003) 625.
7. Rafacho A, Quallio S, Ribeiro DL, Taboga SR, Paula FM, Boschero AC & Bosqueiro JR, The adaptive compensations in endocrine pancreas from glucocorticoid-treated rats are reversible after the interruption of treatment, Acta Physiol, 200 (2010) 223.
8. Rafacho A, Abrantes JL, Ribeiro DL, Paula FM, Pinto ME, Boschero AC & Bosqueiro JR, Morphofunctional alterations in endocrine pancreas of short- and long-term dexamethasone-treated rats, Horm Metab Res, 43 (2011) 275.
9. Rafacho A, Boschero AC & Ortsäter H, Functional and molecular aspects of glucocorticoid in the endocrine pancreas and glucose homeostasis, in State of the art of therapeutic endocrinology (InTech, Rijeka) 2012 121.
10. van Raalte DH, Nofrate V, Bunck MC, van Iersel T, Elassaiss Schaap J, Nässander UK, Heine RJ, Mari A, Dokter WH & Diamant M, Acute and 2-week exposure to prednisolone impair different aspects of beta-cell function in healthy men, Eur J Endocrinol, 162 (2010) 729.
11. Willi SM, Kennedy A, Wallace P, Ganaway E, Rogers NL & Garvey WT, Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin, Diabetes, 51 (2002) 2895.
12. Thomas CR, Turner SL, Jefferson WH & Bailey CJ, Prevention of dexamethasone-induced insulin resistance by metformin, Biochem Pharmacol, 56 (1998) 1145.
13. Ragavan B & Krishnakumari S, Effect of terminalia arjuna stem bark extract on the activities of marker enzymes in alloxan induced diabetic rats, AncSci Life, 25 (2005) 8.
14. Ragavan B & Krishnakumari S, Antidiabetic effect of T. arjuna bark extract in alloxan induced diabetic rats, Indian J Clin Biochem, 21 (2006) 123.
15. Manna P, Sinha M & Sil PC, Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways, Toxicology, 257 (2009) 53.
16. Biswas M, Kar B, Bhattacharya S, Kumar RB, Ghosh AK & Haldar PK, Antihyperglycemic activity and antioxidant role of Terminalia arjuna leaf in streptozotocin-induced diabetic rats, Pharm Biol, 49 (2011) 335.
17. Manna P, Das J, Ghosh J & Sil PC, Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF- kappaB, MAPKs, and mitochondria-dependent pathways: Prophylatic role of arjunolic acid, Free RadicBiol Med, 48 (2010) 1465.
18. Facundo V, Rios KA, Medeiros CM, Militão JSLT, Miranda AL, Epifanio RA, Carvalho MP, Andrade AT, Pinto AC & Rezende CM, Arjunolic acid ethanolic extract of Combretum leprosum root and its use as a potential multi-functional phytomedicine and drug for neurodegenerative disorders: anti-inflammatory and anticholinesterasic activities, J Braz Chem Soc, 16 (2005) 1309.
19. Rafacho A, Marroquí L, Taboga SR, Abrantes JL, Silveira LR, Boschero AC, Carneiro EM, Bosqueiro JR, Nadal A & Quesada I, Glucocorticoids in vivo induce both insulin hypersecretion and enhanced glucose sensitivity of stimulus- secretion coupling in isolated rat islets, Endocrinology, 151 (2010) 85.
20. Paula FM, Boschero AC, Carneiro EM, Bosqueiro JR & Rafacho A, Insulin signaling proteins in pancreatic islets of insulin-resistant rats induced by glucocorticoid, Biol Res, 44 (2011) 251.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostatic model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28 (1985) 412.
22. Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-Gonzales SO, Jacques-Camarena O & Rodríguez-Morán M, The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic- hyperinsulinemic clamp, J Clin Endocrinol Metab, 95 (2010) 3347.
23. Lo S, Russell JC & Taylor AW, Determination of glycogen in small tissue samples, J Appl Physiol, 28 (1970) 234.
24. Giozzet VA, Rafacho A, Boschero AC, Carneiro EM & Bosqueiro JR, Dexamethasone treatment in vivo counteracts the functional pancreatic islet alterations caused by malnourishment in rats, Metabolism, 57 (2008) 617.
25. Tietze F, Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem, 27 (1969) 502.
26. Draper HH, Hadley M, Malondialdehyde determination as index of lipid peroxidation, Methods Enzymol, 186 (1990) 421.
27. Reznick AZ, Packer L, Oxidative damage to proteins: Spectrophotometric method for carbonyl assay, Methods Enzymol, 233 (1994) 357.
28. Weir GC & Bonner-Weir S, Five stages evolving beta-cell dysfunction during progression to diabetes, Diabetes, 53 (2004) suppl.3 S16.
29. Burén J, Lai YC, Lungdren M, Eriksson JW & Jensen J. Insulin action and insulin signaling in fat and muscle from dexamethasone-treated rats, Arch Biochem Biophys, 474 (2008) 91.
30. Mokuda O, Sakamoto Y, Ikeda T & Mashiba H. Sensitivity and responsiveness of glucose output to insulin in isolated perfused liver from dexamethasone-treated rats, Horm Metab Res, 23 (1991) 53.
31. Longano CA & Fletcher HP, Insulin release after acute hydrocortisone treatment in mice, Metabolism, 32 (1983) 603.
32. Manna P & Sil PC. Impaired redox signaling and mitochondrial uncoupling contributes vascular inflammation and cardiac dysfunction in type 1 diabetes: Protective role of arjunolic acid, Biochimie, 94 (2012) 786.
33. Muoio DM & Newgard CB, Obesity-related derangements in metabolic regulation, Annu Rev Biochem, 75 (2006) 367.